NCT01925547View on ClinicalTrials.gov

Micellar Curcumin and Metabolic Syndrome Biomarkers

PHASE2CompletedINTERVENTIONAL
Enrollment

42

Participants

Timeline

Start Date

July 31, 2013

Primary Completion Date

March 31, 2014

Study Completion Date

October 31, 2014

Conditions
Metabolic Syndrome, Protection Against
Interventions
DIETARY_SUPPLEMENT

Micellar curcumin

80 mg micellar curcumin (oral) three times a day for six weeks

DIETARY_SUPPLEMENT

Placebo

Only the excipients (without curcumin) used to prepare the curcumin micelles are given as placebo.

Trial Locations (1)

70599

Institute of Biological Chemistry and Nutrition, University of Hohenheim, Stuttgart

All Listed Sponsors
collaborator

German Federal Ministry of Education and Research

OTHER_GOV

lead

University of Hohenheim

OTHER

NCT01925547 - Micellar Curcumin and Metabolic Syndrome Biomarkers | Biotech Hunter | Biotech Hunter